Stockholders' Equity - Summary of Company's Restricted Share Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning balance (in shares)	397
Granted (in shares)	0
Exercised (in shares)	(203)
Canceled/forfeited (in shares)	(3)
Expired (in shares)	(60)
Ending balance (in shares)	131	397
Exercisable (in shares)	125
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning balance (in dollars per share)	$ 2.89
Weighted average exercise price, granted (in dollars per share)	0
Weighted average exercise price, exercised (in dollars per share)	3.14
Weighted average exercise price, canceled/forfeited (in dollars per share)	2.24
Weighted average exercise price, expired (in dollars per share)	3.97
Weighted average exercise price, ending balance (in dollars per share)	4.08	$ 2.89
Weighted average exercise price, exercisable (in dollars per share)	$ 4.18
Weighted-average remaining contractual term, outstanding	4 years 8 months 12 days	5 years 8 months 12 days
Weighted-average remaining contractual term, exercisable	3 years 6 months
Aggregate intrinsic value outstanding	$ 143	$ 998
Aggregate intrinsic value exercisable	$ 131